By Dan Kedmey
South Korean hospitals have launched clinical trials for an experimental treatment of Middle East Respiratory Syndrome, a potentially lethal virus that has claimed 19 lives since it first broke out across the country four weeks ago.
The country’s health ministry said Tuesday that two hospitals will use blood plasma from patients who recovered from the disease to treat those who are currently infected, the BBC reports.
Some 150 South Koreans have tested positive for MERS and a further 5,200 have been quarantined as officials work to contain the outbreak. The first lethal infection reached Germany on Tuesday, as a 65-year-old man succumbed to the disease in a clinic in Osnabruck.
[BBC]
More Must-Reads From TIME
- The 100 Most Influential People of 2024
- Coco Gauff Is Playing for Herself Now
- Scenes From Pro-Palestinian Encampments Across U.S. Universities
- 6 Compliments That Land Every Time
- If You're Dating Right Now , You're Brave: Column
- The AI That Could Heal a Divided Internet
- Fallout Is a Brilliant Model for the Future of Video Game Adaptations
- Want Weekly Recs on What to Watch, Read, and More? Sign Up for Worth Your Time
Contact us at letters@time.com